Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Electrophysiology Devices Market Worth US$4.4 billion by 2015

April 22, 2013 12:36 pm | by PR Newswire | News | Comments

DALLAS, April 22, 2013 /PRNewswire-iReach/ -- "Global Electrophysiology (EP) Devices- Market Growth Analysis, 2009-2015" and "Electrophysiology (EP) Devices – Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" are new reports available at RnR...

TriReme Receives Shonin Approval to Market Glider™ PTCA Catheter

April 22, 2013 9:01 am | by PR Newswire | News | Comments

PLEASANTON Calif. and SINGAPORE, April 22, 2013 /PRNewswire/ -- TriReme Medical, Inc. and its affiliates (TriReme) announced today that its Japanese partner, Century Medical, Inc. (CMI), has received Shonin approval for the Glider™ PTCA catheter indicated for treating the...

Healthcare's First Direct Contracting Market Launches Today; Will Offer Mutually Beneficial Approach for Hospitals and Suppliers

April 22, 2013 9:00 am | by PR Newswire | News | Comments

IRVING, Texas, April 22, 2013 /PRNewswire/ -- Today aptitude announced the launch of the healthcare industry's first online direct contracting market, a one-stop destination designed to complement a hospital's existing contracting model or provide an alternative for those looking...

Advertisement

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for Gencaro

April 22, 2013 8:00 am | by The Associated Press | News | Comments

BROOMFIELD, Colo.--(BUSINESS WIRE)--Apr 22, 2013--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc. (NYSE:MDT), a leader in medical...

ZOLL and Reflectance Medical Form Development Agreement to Incorporate Mobile CareGuide Sensor into ZOLL Monitor/Defibrillators

April 18, 2013 10:18 am | by The Associated Press | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--Apr 18, 2013--ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced today that it has entered into an agreement with Reflectance Medical, Inc. of Westborough, Mass., to develop and market a ruggedized...

Hand-Held Device Provides Lab-Quality Troponin Test Results in 15 Minutes to Identify Patients Suspected of Heart Attack

April 18, 2013 8:31 am | by The Associated Press | News | Comments

Silicon BioDevices, based in Berkeley, Calif., today presented the results of a pivotal benchmark study of its digital handheld device for high-sensitivity measurement of cardiac troponin-I, a protein found in the heart muscle used to identify heart tissue damage in patients suspected of having a heart attack.

Vasomedical Introduces Policy Makers Focusing on Healthcare Reform to EECP@ Therapy

April 16, 2013 8:30 am | by The Associated Press | News | Comments

Currently, the United States spends more on healthcare services than any other country, exceeding $2.6 trillion, or about 18 percent of gross domestic product, annually. Most years, medical spending rises faster than inflation and the economy as a whole, which makes this a top priority for...

American College of Cardiology Journal Publishes Outcomes of Diabetes Patients Treated with Medtronic's Resolute Stent

April 15, 2013 9:06 am | by The Associated Press | News | Comments

The current issue of JACC: Cardiovascular Interventions, a peer-reviewed journal published by the American College of Cardiology, includes an article that describes how the Resolute Integrity drug-eluting stent from Medtronic became the first and only device of its kind to be approved by the FDA with a specific indication for treating the coronary artery disease of patients with diabetes mellitus.

Advertisement

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions

April 15, 2013 9:00 am | by The Associated Press | News | Comments

BOTHELL, Wash.--(BUSINESS WIRE)--Apr 15, 2013--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis...

Stenting Blocked Bowel Arteries Saves Lives

April 14, 2013 10:00 am | by PR Newswire | News | Comments

Stenting reopens completely blocked bowel arteries, preventing damage and even death from a condition that causes individuals severe pain and leads to excessive weight loss, notes research being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans, La.

St. Jude-backed iRhythm Technologies raises another $16M for Zio wearable heart monitor

April 12, 2013 10:48 am | by Mass Device | News | Comments

iRhythm Technologies said it closed a $16 million Series D round for its Zio wearable heart monitor, saying it plans to use the proceeds to further its commercial footprint and research & development efforts. Led by Norwest Venture Partners, which added partner Casper de Clercq to iRhythm's board, the latest financing including contributions from existing backers...

Franciscan St. Francis Health Is First Hospital in Nation to Implant Breakthrough Aortic Heart Valve Device

April 11, 2013 2:30 pm | by PR Newswire | News | Comments

INDIANAPOLIS, April 11, 2013 /PRNewswire-USNewswire/ -- Franciscan St. Francis Health is the first hospital in the United States to implant a new device that could improve the quality of life for patients with aortic valve disease. The On-X® Aortic Prosthetic Valve with...

Medtronic’s Endurant ‘AAA’ Stent Graft Shows Sustained Durability in Complex Patients

April 11, 2013 11:21 am | by Medtronic | News | Comments

Presented to endovascular specialists at the 35th Charing Cross International Symposium in London, a new analysis of clinical data on the Endurant AAA Stent Graft System from Medtronic demonstrates the implanted medical device’s consistent and compelling performance in treating abdominal aortic aneurysms across a range of patient anatomies.

Advertisement

U-M Researchers Find New Way to Clear Cholesterol from the Blood

April 11, 2013 10:59 am | by University of Michigan | News | Comments

Researchers at the University of Michigan have identified a new potential therapeutic target for lowering cholesterol that could be an alternative or complementary therapy to statins. Scientists in the lab of David Ginsburg at the Life Sciences Institute inhibited the action of a gene responsible for transporting a protein that interferes with the ability of the liver to remove cholesterol from the blood in mice.

Global Clinical Study Initiated to Determine Safety and Effectiveness of Stent for Patients with Iliofemoral Venous Obstruction

April 11, 2013 9:00 am | by The Associated Press | News | Comments

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Apr 11, 2013--Cook Medical has launched the VIVO clinical research study to evaluate the safety and effectiveness of the Zilver ® Vena™ Venous Self-Expanding Stent in the treatment of symptomatic iliofemoral venous outflow obstruction. This disease is...

U.S. Healthcare Groups Taking a Closer Look at Medical Implants

April 10, 2013 1:14 pm | by Mass Device | News | Comments

A quartet of U.S. healthcare groups are teaming up to take a closer look at the long-term effectiveness of medical implants, launching independent clinical studies in order to evaluate devices and their outcomes for patients, the group announced this week.

Theragenics Launches Torx™ Transitionless Guidewires

April 10, 2013 7:28 am | by The Associated Press | News | Comments

BUFORD, Ga.--(BUSINESS WIRE)--Apr 10, 2013--Theragenics Corporation ® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced that Galt Medical (a wholly-owned subsidiary of Theragenics) launched its Torx™ transitionless guidewire...

Real-Time Navigation of Left Ventricular Leads

April 9, 2013 10:50 am | by Medtronic | News | Comments

Medtronic (NYSE:MDT) has announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and CRT-D), in the United States and Canada.

AdvaMed 2013: The MedTech Conference

April 8, 2013 3:37 pm | by MDT Staff | Events

AdvaMed 2013 is the leading MedTech conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking.

Patients Slap St. Jude Medical with Lawsuits over Recalled Riata Heart Wires

April 5, 2013 2:27 pm | by Mass Device | News | Comments

St. Jude Medical was slapped with multiple lawsuits in California courts yesterday over its recalled Riata defibrillator lead, alleging that the heart wires were defective and led to injuries or death for more than 30 patients. The lawsuits generally accuse St. Jude of violating both state and federal requirements for reporting issues with medical devices...

Court Overturns $482M Patent Decision Against J&J

April 5, 2013 9:26 am | by The Associated Press | News | Comments

A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.

Symetis Touts Positive Findings for Its Acurate TA TAVI System

April 4, 2013 4:21 pm | by Mass Device | News | Comments

Swiss medical device maker Symetis released 30-day registry findings for its 2nd-generation transcatheter aortic valve implantation systems, touting high procedural success rates and minimal valve leakage. Results from the SAVI postmarket registry highlighted findings from the 1st 250 patients implanted with Symetis' Acurate TA TAVI system, which won European regulatory approval in September 2011.

Stealthy AtheroMed Raises $6M for Peripheral Atherectomy Device

April 4, 2013 12:24 pm | by Mass Device | News | Comments

AtheroMed said it's raised a $6 million equity round, taking its total funding raise since 2009 to $20 million, according to regulatory filings. The Menlo Park, Calif.-based medical device company is developing an atherectomy device for treating peripheral artery disease, according to its website.

Rapid Increase In Sclerosant Use Will Drive Steady Expansion Of US Varicose Vein Treatment Device Market

April 4, 2013 8:00 am | by PR Newswire | News | Comments

TORONTO, April 4, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, growth in the United States market for varicose vein treatment devices will be driven largely by strong growth in the sclerotherapy...

The Heart and Vascular Center Bad Bevensen Treats First Patients in Germany With Hansen Medical's Magellan Robotic System

April 3, 2013 4:03 pm | by The Associated Press | News | Comments

Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that the Heart and Vascular Center Bad Bevensen has performed the first successful cases with the Magellan™ Robotic System in Germany. These cases were performed by Dr. Thomas Nolte, Director...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading